BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2800817&ei=knKaUpCMFoqw0AGZAw&usg=AFQjCNEgrTZmIjOkvQvGCsxbPva1ICdnRQ
Biogen Idec Inc Raises FY 2013 Guidance
Thursday, 25 Jul 2013 07:01am EDT
Biogen Idec Inc increased its fiscal 2013 guidance and expects revenue growth to be approximately 22% to 23%, Non-GAAP diluted EPS to be between $8.25 and $8.50 and GAAP diluted EPS is expected to be between $7.28 and $7.53. The Company reported revenues of $5.5 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $6.64 billion and EPS of $8.22 for fiscal 2013.Â 
